Effect of switching with oral contraceptives
- PMID: 12254511
Effect of switching with oral contraceptives
Abstract
PIP: Women requesting family planning advice at the Family Planning Clinic at El-Galaa Hospital in Cairo participated in a study investigating some of the main clinicopathological aspects of switching from 1 oral contraceptive to another. The pills were Vestalin M (2.5 mg vinylestrenelone, .1 mg ethinyl estradiol), Vestalin Uno (1 mg vinylestrenelone, .1 mg ethinyl estradiol), Gynovlar (3 mg article says "m" norethisterone acetate, .05 mg ethinyl beta-estradiol), and chlormadinone, .5 mg. Controls used either Vestalin M (68) or Vestalin Uno (55) for 6 months. 24 users of Vestalin M (average 11 months use) switched to Vestalin Uno, thus changing from a higher to lower level of gestagen. 26 users of Vestalin Uno switched to Vestalin M. 3 groups switched from 1 chemical composition to another: 41 Gynovlar users of average 6 months switched to Vestalin Uno, 14 chlormadinone users of average 24 months switched to Vestalin Uno, and 18 chlormadinone users of average 18 months switched to Vestalin M. Post-menstrual endometrial biopsies (cycle days 5-7) were taken before the start of first therapy, before the switch, and at the end of the second drug's trial. Percentages of participants with first-cycle amenorrhea, hypomennorhea, and breakthrough bleeding were 7.5, 3.9, and 9.4 with Vestalin M and 2.0, 8.0, and 2.0 with Vestalin Uno. However, by the fifth cycle, the percentages with hypomennorhea were 25.8 and 12.2, respectively. The high gestagen level reduced the number of endometrial glands and the height of the lining epithelium and caused and excessive decidual reaction of the stroma, a reaction gradually involving the endometrium's compact basal layer, which has no involvement with the luteinization process of the secretory phase in normal women. The material shed included the necks of the endometrial glands responsible for the regeneration of the endometrium in subsequent cycles. When switching from a high to a low gestagen level, the endometrium regenerated and withdrawal bleeding lessened markedly in amount and duration. A few, less systematic, observations are reported for the women changing from 1 chemical composition to another.
Similar articles
-
Control of fertility with oral medication.West J Surg Obstet Gynecol. 1964 Jul-Aug;72:222-9. West J Surg Obstet Gynecol. 1964. PMID: 12305556
-
Pill-a-month as an oral contraceptive.Egypt Popul Fam Plann Rev. 1972 Jun;5(1):1-17. Egypt Popul Fam Plann Rev. 1972. PMID: 12256024
-
Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.Egypt Popul Fam Plann Rev. 1972 Jun;5(1):41-65. Egypt Popul Fam Plann Rev. 1972. PMID: 12256027
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
-
Menstrual impact of contraception.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1513-22. doi: 10.1016/s0002-9378(94)05013-1. Am J Obstet Gynecol. 1994. PMID: 8178900 Review.